Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide☆☆☆-Reference-Cited by-同舟云学术

Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide☆☆☆

Published:2011-04 Issue:4 Volume:39 Page:e59-e67
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:European Journal of Cardio-Thoracic Surgery

Author:

Caimmi Philippe Primo,Molinari Claudio,Uberti Francesca,Micalizzi Ezio,Valente Guido,Mary David A.S.G.,Vacca Giovanni,Grossini Elena

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/39/4/e59/17792639/39-4-e59.pdf

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderate Hyperkalemia Regulates Autophagy to Reduce Cerebral Ischemia-Reperfusion Injury in a CA/CPR Rat Model;Brain Sciences;2023-09-04

2. Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology;Biomolecules;2023-08-24

3. Levosimendan‐induced venodilation is mediated by opening of potassium channels;ESC Heart Failure;2021-10-30

4. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety;Expert Review of Cardiovascular Therapy;2021-04-02

5. Comprehensive Comparisons among Inotropic Agents on Mortality and Risk of Renal Dysfunction in Patients Who Underwent Cardiac Surgery: A Network Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2021-03-03